A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial

Peer Review reports

Original Submission
23 Jul 2023	Submitted	Original manuscript
12 Aug 2023	Reviewed	Reviewer Report - Matthias Briel
22 Aug 2023	Author responded	Author comments - Flavia Lucia Lombardo
Resubmission - Version 2
22 Aug 2023	Submitted	Manuscript version 2
Publishing
22 Aug 2023	Editorially accepted
5 Dec 2023	Article published	10.1186/s13063-023-07638-w

Back to article page